Dig Dis News Today

Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.

While more studies are needed to ensure the safety of long-term therapy with PCABs, this study establishes a role for the use of vonoprazan in the healing and maintenance of healing in patients with erosive esophagitis.

Individuals with a prior appendectomy do not have an increased risk for Clostridioides difficile infection.

Objective To characterize patients with celiac disease (CD), examines the clinical spectrum of CD, and evaluate the performance of serologic tests used for CD screening, in the United Arab Emirates (UAE). Method Medical charts of patients received at the Digestive Diseases Institute of Cleveland Clinic Abu Dhabi from January 2015 to December 2020 were reviewed. Patients who were screened for four serologic biomarkers (anti-tissue transglutaminase IgA [Anti-tTG-IgA], anti-tissue transglutaminase ...

/PRNewswire/ -- The University of Texas MD Anderson Cancer Center and Federation Bio, a biotechnology company pioneering bacterial cell therapies, today...

Elucidating the mechanisms by which PPIs increase cardiovascular events, thereby reminding clinicians to rationally prescribe PPIs. Learn more inside.

Since 1985, KUVO has provided a rare blend of music & news. We broadcast the best in Jazz, Latin Jazz & Blues in addition to 17 locally produced, culturally diverse programs.

TOTUM•448 is an innovative plant-based patented active substance developed by Valbiotis, a young French SME, to counteract the development of metabolic liver diseases (NAFL and NASH1 In two

A broad overview of the role vitamin D in the immune system, especially in the pathogenesis & treatment of IBD, & its possible role in predicting relapse.

/PRNewswire/ -- Freenome, a privately held biotech company, presented research at the American Society of Preventive Oncology (ASPO) annual meeting. The...